Proxima
PrivateLast Round
Series B
Jun 10, 2026
Total Funding Raised
$80.33M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Proxima is a biotechnology company that provides an AI-driven drug discovery platform for proximity therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proxima Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Proxima Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 10, 2026 | ||||
| Seed | Jan 13, 2026 | ||||
| Pre Seed | Oct 10, 2024 | ||||
| Grant | May 24, 2023 |
Key People
Founding team and executive leadership
Proxima Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Seed |
| Braidwell | Seed |
| Magnetic Ventures | Seed |
| NVentures | Seed |
| Yosemite | Seed |
| Alexandria Venture Investments | Seed |
| NVentures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 10, 2026
$91M round completed.
- Apr 1, 2026
Launched Neo-1, an all-atom foundation model for molecular generation.
Proxima Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Proxima's valuation, stock price, and market status.